Trades on 2 secondary markets

Outpace Bio

Outpace Bio is a clinical-stage biotechnology company applying AI-powered protein design to cell therapy, with the mission of curing solid tumors. The company engineers novel proteins that reprogram immune cells to overcome the limitations of current cancer immunotherapies, built on a set of proprie

minimal 12.3 / 100 0 APIs View provider profile →

Company Engineered Biology Biotechnology Cell Therapy Protein Design Oncology

Outpace Bio is an API provider whose private shares are listed on 2 secondary markets: EquityZen, Nasdaq Private Market.

Where It Trades

EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.